Physician Enterprises After COVID-19: Capturing and Assessing Opportunities

Présentation



Physician enterprises will face lasting changes to their operations following the coronavirus (COVID-19) public health emergency. Transactional opportunities have also shifted, and physician enterprises and their counterparts have new factors to consider when assessing and pursuing collaborations and other transactions in a post-COVID-19 world.

Joined by leaders from hospital and health system physician groups, private equity-backed physician groups and strategic healthcare consultants, McDermott Will & Emery will lead the conversation on how physician enterprises can position themselves for success in the new healthcare landscape.

This program will explore:

  • How has COVID-19 changed the healthcare and investing landscape?
  • How can physician practices shift their means of care delivery, including telehealth solutions, now and after COVID-19?
  • How have operational challenges impacted physician practice valuations?
  • What transactional opportunities have arisen from the public health emergency?
  • How can physician enterprises and their counterparts execute successful strategic collaborations?

Registration Information

3:00 pm – 4:15 pm (EDT)

Pour aller plus loin

Anaheim, CA / HCCA / June 8 - 10, 2022

2022 Research Compliance Conference

Webinar / Women's Health USA / January 20, 2022

Key Transaction Considerations in Women's Health

Virtual / McDermott Event / January 10-14, 2022

2022 J.P. Morgan Healthcare Conference

Roundtable / McDermott Event / December 16, 2021

Facing the No Surprises Act - Focus on Hospitals and Health Systems

Webinar Series / McDermott Event / December 2021

Digital Health Venture Series: The Art of Doing a Digital Health Deal

Nous contacter